» Articles » PMID: 33461965

Effect of Green-Mediterranean Diet on Intrahepatic Fat: the DIRECT PLUS Randomised Controlled Trial

Abstract

Objective: To examine the effectiveness of green-Mediterranean (MED) diet, further restricted in red/processed meat, and enriched with green plants and polyphenols on non-alcoholic fatty liver disease (NAFLD), reflected by intrahepatic fat (IHF) loss.

Design: For the DIRECT-PLUS 18-month randomized clinical trial, we assigned 294 participants with abdominal obesity/dyslipidaemia into healthy dietary guidelines (HDG), MED and green-MED weight-loss diet groups, all accompanied by physical activity. Both isocaloric MED groups consumed 28 g/day walnuts (+440 mg/day polyphenols provided). The green-MED group further consumed green tea (3-4 cups/day) and Mankai (a aquatic plant strain; 100 g/day frozen cubes) green shake (+1240 mg/day total polyphenols provided). IHF% 18-month changes were quantified continuously by proton magnetic resonance spectroscopy (MRS).

Results: Participants (age=51 years; 88% men; body mass index=31.3 kg/m; median IHF%=6.6%; mean=10.2%; 62% with NAFLD) had 89.8% 18-month retention-rate, and 78% had eligible follow-up MRS. Overall, NAFLD prevalence declined to: 54.8% (HDG), 47.9% (MED) and 31.5% (green-MED), p=0.012 between groups. Despite similar moderate weight-loss in both MED groups, green-MED group achieved almost double IHF% loss (-38.9% proportionally), as compared with MED (-19.6% proportionally; p=0.035 weight loss adjusted) and HDG (-12.2% proportionally; p<0.001). After 18 months, both MED groups had significantly higher total plasma polyphenol levels versus HDG, with higher detection of and 2-5-dihydroxybenzoic-acid in green-MED. Greater IHF% loss was independently associated with increased Mankai and walnuts intake, decreased red/processed meat consumption, improved serum folate and adipokines/lipids biomarkers, changes in microbiome composition (beta-diversity) and specific bacteria (p<0.05 for all).

Conclusion: The new suggested strategy of green-Mediterranean diet, amplified with green plant-based proteins/polyphenols as Mankai, green tea, and walnuts, and restricted in red/processed meat can double IHF loss than other healthy nutritional strategies and reduce NAFLD in half.

Trial Registration Number: NCT03020186.

Citing Articles

Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells.

Khalifa O, Ayoub S, Arredouani A Biomedicines. 2025; 13(2).

PMID: 40002783 PMC: 11853215. DOI: 10.3390/biomedicines13020370.


Reframing Diabetes Prevention: From Body Shaming to Metabolic Reprogramming.

Adams M, Enichen E, Demmig-Adams B Am J Lifestyle Med. 2025; 19(2):168-191.

PMID: 39981552 PMC: 11836583. DOI: 10.1177/15598276231182655.


Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.

Takawy M, Abdelmalek M Curr Diab Rep. 2025; 25(1):23.

PMID: 39964660 DOI: 10.1007/s11892-025-01579-1.


Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches.

Cogorno L, Formisano E, Vignati A, Prigione A, Tramacere A, Borgarelli C Liver Res. 2025; 7(3):216-227.

PMID: 39958388 PMC: 11791914. DOI: 10.1016/j.livres.2023.08.005.


Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.

Hao X, Song H, Su X, Li J, Ye Y, Wang C Ann Med. 2025; 57(1):2464223.

PMID: 39943720 PMC: 11827040. DOI: 10.1080/07853890.2025.2464223.


References
1.
Shai I, Rosner B, Shahar D, Vardi H, Azrad A, Kanfi A . Dietary evaluation and attenuation of relative risk: multiple comparisons between blood and urinary biomarkers, food frequency, and 24-hour recall questionnaires: the DEARR study. J Nutr. 2005; 135(3):573-9. DOI: 10.1093/jn/135.3.573. View

2.
Szczepaniak L, Nurenberg P, Leonard D, Browning J, Reingold J, Grundy S . Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2004; 288(2):E462-8. DOI: 10.1152/ajpendo.00064.2004. View

3.
Da Silva H, Teterina A, Comelli E, Taibi A, Arendt B, Fischer S . Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci Rep. 2018; 8(1):1466. PMC: 5780381. DOI: 10.1038/s41598-018-19753-9. View

4.
Friedrich-Rust M, Muller C, Winckler A, Kriener S, Herrmann E, Holtmeier J . Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers. J Clin Gastroenterol. 2009; 44(1):58-65. DOI: 10.1097/MCG.0b013e3181a84b8d. View

5.
Hernandez-Aquino E, Muriel P . Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J Gastroenterol. 2018; 24(16):1679-1707. PMC: 5922990. DOI: 10.3748/wjg.v24.i16.1679. View